The Hospital del Mar Medical Research Institute is leading the study that will evaluate whether a new molecule can be used to improve cognitive performance in people with Down syndrome.
The study is part of the ICOD (Improving Cognition in Down Syndrome), promoted by the European Union within the framework of the Horizon 2020 R&D funding program, with a grant of six million euros. The IMIM-Hospital de Mar team is led by Dr. Rafael de la Torre, and its ultimate goal is to achieve a treatment that improves the working memory of people with Down syndrome, a key cognitive deficit in this pathology. Working memory refers to language comprehension, reading, mathematical skills, learning and reasoning.
The treatment has already passed the trial phase with volunteers without Down syndrome, which was intended to certify the safety and tolerability of the drug.
This new phase will validate the safety of the treatment in people with Down syndrome and will provide the first indications of efficacy. It is estimated that the results could be available by mid-2023. This is the first study to analyse the feasibility of a new type of approach in this field.
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. |
_ga_2DMP7XMBDL | 2 years | This cookie is installed by Google Analytics. |
Cookie | Duration | Description |
---|---|---|
pll_language | 1 year | The pll _language cookie is used by Polylang to remember the language selected by the user when returning to the website, and also to get the language information when not available in another way. |
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-analytics | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category . |
cookielawinfo-checkbox-functional | 1 year | The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category . |
cookielawinfo-checkbox-others | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others". |
cookielawinfo-checkbox-performance | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance". |
CookieLawInfoConsent | 1 year | Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. |
elementor | never | This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time. |